USFDA clears Plursitem for expanded access programPatients suffering from critical limb ischemia can now benefit without being part of clinical trialsA Pluristem scientist at work.(photo credit: PLURISTEM)
A Pluristem scientist at work.(photo credit: PLURISTEM)Updated: